3 week ago - Translate

AI in Clinical Trials Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035

Date of Publication: 2025-Jul-14

The AI in Clinical Trials Market report offers a thorough analysis of the global market, delivering valuable insights into current trends, business strategies, and a comprehensive examination of key factors influencing the market’s trajectory. The report explores critical aspects of the AI in Clinical Trials industry, including market drivers, challenges, growth prospects, and risks, along with an in-depth look at the competitive landscape and regional variations.

The global AI in Clinical Trials market size is estimated to grow from USD 1.82 billion in 2025 to USD 8.5 billion by 2035, representing a CAGR of 16.7% during the forecast period till 2035. The AI in Clinical Trials Market has seen notable developments in recent years, with an increasing number of agricultural stakeholders turning to AI in Clinical Trials as a safer alternative to chemical pesticides. This shift is driven by growing awareness of the environmental and health impacts of traditional pesticides. As global farming practices continue to evolve, the demand for sustainable and eco-friendly crop protection solutions has escalated. The report outlines how these changing market dynamics are influencing both established companies and new entrants in the industry.

The report provides an in-depth analysis of the evolving market segments, giving a detailed overview of the factors that impact AI in Clinical Trials adoption. It discusses the increasing product offerings within the market and how emerging technologies are shaping the landscape. Strategic initiatives such as mergers, acquisitions, and partnerships are also highlighted, as they play a key role in expanding market reach and improving product offerings. The insights provided help stakeholders understand the competitive forces at play and guide their strategies in the market.

The market for AI in Clinical Trials is segmented into several categories, such as.

Target Therapeutic Area
Cardiovascular Disorders
CNS Disorders
Infectious Diseases
Metabolic Disorders
Oncological Disorders
Other Disorders

End-user
Pharmaceutical and Biotechnology Companies
Other End-users

Reference: https://www.rootsanalysis.com/....reports/ai-based-cli

The AI in Clinical Trials Market is analyzed across various regions, including Asia-Pacific, Europe, Latin America, Middle East and North Africa, North America.

Key players in the AI in Clinical Trials Market include AiCure, Antidote Technologies, Deep 6 AI, Innoplexus, IQVIA, Median Technologies, Medidata, Mendel.ai, Phesi, Saama Technologies, Signant Health, Trials.ai. These companies are leading the way in AI in Clinical Trials innovation, continuously introducing new products and expanding their global presence. Their efforts are focused on enhancing product efficiency and meeting the increasing demand for AI in Clinical Trials solutions worldwide.

The report also includes an analytical overview of the AI in Clinical Trials industry, utilizing tools like SWOT analysis, clinical trial analysis, partnerships and collaborations, funding and investment analysis, big pharma initiatives and Porter’s Five Forces to assess the competitive landscape and market dynamics. This provides a deeper understanding of market competition, potential risks, and areas of opportunity, offering actionable insights for stakeholders to navigate the industry.

In conclusion, this report offers a comprehensive view of the AI in Clinical Trials Market, providing valuable insights into the market’s current state and future prospects. It examines the key drivers, regional trends, and competitive strategies that are shaping the future of AI in Clinical Trials. With its detailed analysis, the report is an essential resource for stakeholders looking to make informed decisions in this growing industry.

About Roots Analysis

Who Are They

Roots Analysis is a globally recognized provider of market intelligence, competitive research, and consulting services.
With 12+ years of experience, the company has worked with 750+ clients across the globe — including Fortune 500 companies, emerging start-ups, academic institutions, and strategic investors.
Backed by a network of 450,000+ senior professionals, Roots Analysis delivers data-driven insights that guide business-critical decisions.
The firm serves a diverse set of high-impact industries, including Life Sciences, Semiconductors & Electronics, Chemicals & Materials, and Information & Communication Technology (ICT), making them a trusted partner across innovation-driven sectors.
The firm is known for quality of their research, completeness and depth of the research. The team is actively working with numerous global clients to support key decision-makers, smart insights for revenue impact decisions, strategic growth.

What They Do
Roots Analysis helps organizations understand and respond to evolving markets and emerging technologies.
They offer data-backed insights that support informed decision-making and long-term strategy development.
Their team continuously monitors innovation and disruption across high-impact sectors, identifying growth opportunities early on.

What They Offer
Syndicated Market Reports – Structured, in-depth reports covering niche and fast-evolving markets.
Custom Research & Consulting – Bespoke studies designed to align with specific business goals and challenges.
Competitive Intelligence Solutions – Deep market mapping, pipeline analysis, partnership tracking, and investor profiling.

What Sets Them Apart
Sector Expertise – Especially strong in pharmaceuticals, biotechnology, healthcare, and deep tech.
Analytical Strength – Research is grounded in robust methodologies, real-world data, and strategic foresight.
Client-Centric Approach – Every engagement is tailored, no generic solutions.
Global Credibility – Trusted by decision-makers and thought leaders around the world.
Forward-Looking Vision – Roots Analysis focuses not just on where markets are, but where they’re heading.

Contact Details for Roots Analysis

Chief Executive: Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com

Website: https://www.rootsanalysis.com/

AI in Clinical Trials Market Size & Share | Global Report, 2035

The global AI in Clinical Trials market size is estimated to grow from USD 1.82 billion in 2025 to USD 8.5 billion by 2035, representing a CAGR of 16.7% during the forecast period 2025-2035.